1.Association Between Burnout and Intention to Emigrate in Peruvian health-care Workers
Alexander ANDUAGA-BERAMENDI ; Renato BEAS ; Jesus MATICORENA-QUEVEDO ; Percy MAYTA-TRISTÁN
Safety and Health at Work 2019;10(1):80-86
BACKGROUND: Emigration of health-care workers is a problem within global health systems which affects many countries, including Peru. Several factors have caused health-care workers to emigrate, including burnout syndrome (BS). This study aims to identify the association between BS and its dimensions with the intention of physicians and nurses to emigrate from Peru in 2014.
Anxiety Disorders
;
Cross-Sectional Studies
;
Emigration and Immigration
;
Global Health
;
Health Personnel
;
Humans
;
Intention
;
Logistic Models
;
Male
;
Odds Ratio
;
Peru
;
Prevalence
2.Cognitive Impairment and Insomnia in Celiac Disease:A Systematic Review and Meta-Analysis
Renato BEAS ; Ambar GODOY ; Dalton A. NORWOOD ; Ysaith Orellana ASCENCIO ; Diego IZQUIERDO-VERAZA ; Eleazar E. MONTALVAN-SANCHEZ ; Mirian RAMIREZ ; Satya KURADA
Gut and Liver 2024;18(6):1080-1084
Emerging evidence suggests a broader spectrum of celiac disease (CeD) system involvement, including neurological manifestations. We aimed to conduct a systematic review and meta-analysis of the available evidence from studies assessing the association of cognitive impairment and insomnia with CeD. A total of 259 participants with CeD were included in the studies investigating insomnia and 179 were included in studies investigating cognitive impairment. The overall pooled odds ratio for insomnia in patients with CeD was 1.83 (95% confidence interval, 1.38 to 2.42; I 2 =0.00%). The present study provides valuable insights into the available evidence from studies investigating cognitive impairment in patients with CeD and our systematic review and meta-analysis revealed a significant association between CeD and insomnia.
3.Cognitive Impairment and Insomnia in Celiac Disease:A Systematic Review and Meta-Analysis
Renato BEAS ; Ambar GODOY ; Dalton A. NORWOOD ; Ysaith Orellana ASCENCIO ; Diego IZQUIERDO-VERAZA ; Eleazar E. MONTALVAN-SANCHEZ ; Mirian RAMIREZ ; Satya KURADA
Gut and Liver 2024;18(6):1080-1084
Emerging evidence suggests a broader spectrum of celiac disease (CeD) system involvement, including neurological manifestations. We aimed to conduct a systematic review and meta-analysis of the available evidence from studies assessing the association of cognitive impairment and insomnia with CeD. A total of 259 participants with CeD were included in the studies investigating insomnia and 179 were included in studies investigating cognitive impairment. The overall pooled odds ratio for insomnia in patients with CeD was 1.83 (95% confidence interval, 1.38 to 2.42; I 2 =0.00%). The present study provides valuable insights into the available evidence from studies investigating cognitive impairment in patients with CeD and our systematic review and meta-analysis revealed a significant association between CeD and insomnia.
4.Cognitive Impairment and Insomnia in Celiac Disease:A Systematic Review and Meta-Analysis
Renato BEAS ; Ambar GODOY ; Dalton A. NORWOOD ; Ysaith Orellana ASCENCIO ; Diego IZQUIERDO-VERAZA ; Eleazar E. MONTALVAN-SANCHEZ ; Mirian RAMIREZ ; Satya KURADA
Gut and Liver 2024;18(6):1080-1084
Emerging evidence suggests a broader spectrum of celiac disease (CeD) system involvement, including neurological manifestations. We aimed to conduct a systematic review and meta-analysis of the available evidence from studies assessing the association of cognitive impairment and insomnia with CeD. A total of 259 participants with CeD were included in the studies investigating insomnia and 179 were included in studies investigating cognitive impairment. The overall pooled odds ratio for insomnia in patients with CeD was 1.83 (95% confidence interval, 1.38 to 2.42; I 2 =0.00%). The present study provides valuable insights into the available evidence from studies investigating cognitive impairment in patients with CeD and our systematic review and meta-analysis revealed a significant association between CeD and insomnia.
5.Cognitive Impairment and Insomnia in Celiac Disease:A Systematic Review and Meta-Analysis
Renato BEAS ; Ambar GODOY ; Dalton A. NORWOOD ; Ysaith Orellana ASCENCIO ; Diego IZQUIERDO-VERAZA ; Eleazar E. MONTALVAN-SANCHEZ ; Mirian RAMIREZ ; Satya KURADA
Gut and Liver 2024;18(6):1080-1084
Emerging evidence suggests a broader spectrum of celiac disease (CeD) system involvement, including neurological manifestations. We aimed to conduct a systematic review and meta-analysis of the available evidence from studies assessing the association of cognitive impairment and insomnia with CeD. A total of 259 participants with CeD were included in the studies investigating insomnia and 179 were included in studies investigating cognitive impairment. The overall pooled odds ratio for insomnia in patients with CeD was 1.83 (95% confidence interval, 1.38 to 2.42; I 2 =0.00%). The present study provides valuable insights into the available evidence from studies investigating cognitive impairment in patients with CeD and our systematic review and meta-analysis revealed a significant association between CeD and insomnia.
6.Telehealth outpatient monitoring of a SARS-CoV-2 familial cluster infection in Peru: Adapting to a healthcare crisis
José ; Arriola-Montenegro ; Liliana Arriola-Montenegro ; Renato Beas ; Celeste Dí ; az-Pardavé ;
Acta Medica Philippina 2022;56(5):151-156
The coronavirus disease 2019 (COVID-19) epidemic is evolving in Latin America despite implementation of government measures. We report a familial cluster in Lima, Peru, with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Two young and two middle-aged adults with a wide range of COVID-19 manifestations experienced successful management under telehealth outpatient monitoring. Telehealth monitoring was scheduled as suggested by Peruvian Ministry of Health Guidelines and was performed by a designated physician who assessed the patients and prescribed treatment.
On May 14, 2020, a 25-year-old male, who worked treating COVID-19 patients, reported constitutional symptoms and tested positive for SARS-CoV-2. Clinical improvement was achieved with azithromycin and ivermectin therapy. He had been in contact with his parents (Cases 2 and 3) and his sister (Case 4). Cases 2 and 3 developed moderate pulmonary compromise requiring oxygen supplementation and pharmacological therapy, including corticosteroids and anticoagulation, under home medical assessment and telehealth monitoring. Case 4 developed mild symptoms and periorbital rash, an atypical dermatological finding.
To our knowledge this represents the first report of a familial cluster with COVID-19 that was successfully managed under scheduled telehealth outpatient monitoring in Latin America.
SARS-CoV-2
;
COVID-19
;
Telemedicine
;
Remote Consultation